News

Dr. Martin Yaffe, CIMTEC Chief Scientific Officer and Associate Centre Director

Congratulations to Dr. Martin Yaffe! Dr. Martin Yaffe, CIMTEC’s Chief Scientific Officer, has been appointed to the Order of Canada for his...

HTX logo

In March 2015, the Health Technology Exchange (HTX) and the Ontario Ministry of Government and Consumer Services established the new REACH...

KalGene Pharmaceuticals partners with CIMTEC

Toronto, Ontario ─ Canadian biotech KalGene Pharmaceuticals has successfully secured $1.5 million in financing from Brain Canada, CQDM, and...

Biotechnology Focus, CIMTEC launches spin-off company Focal Healthcare, Inc.

CIMTEC: Focused on Commercializing Medical Imaging Technology The Centre for Imaging Technology Commercialization (CIMTEC) is one of the...

CIMTEC

Commercialization 101: A Primer for Medical Imaging Innovators - March 26, 2015 Presenter: Alvira Macanovic, IP, Regulatory and Clinical...

CIMTEC

Intellectual Property Protection and Licensing - March 11, 2015 Panelists: Dr. Gabriella Chan – Founder, Yocto LawMark Penner – Partner,...

CIMTEC article in Canadian Healthcare Technology

False negative diagnoses for prostate cancer are an abiding issue and a significant area of unmet need, therefore improving biopsy and...

CIMTEC

Clinical Testing 101 - January 21, 2015 Presenter: Alvira Macanovic, IP, Regulatory and Clinical Affairs Manager at CIMTEC Description: A...

CIMTEC customer KalGene Pharmaceuticals licensing therapeutic molecule for Alzheimer's from National Research Council of Canada

Kingston, Ontario, January 13, 2015 - National Research Council of Canada (NRC) has granted KalGene Pharmaceuticals an exclusive worldwide...

Dr. Martin Yaffe, CIMTEC Chief Scientific Officer and Associate Centre Director

Dr. Martin Yaffe, CIMTEC’s Associate Centre Director and Chief Scientific Officer, was elected an Honorary Fellow in The Society of Breast...

Pages